Platinum Investment Management LTD Icosavax, Inc. Transaction History

Platinum Investment Management LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$5.95 - $15.79 $5.68 Million - $15.1 Million	-955,374 Reduced 40.9%	1,380,618 $21.8 Million
Q3 2023 Nov 02, 2023	BUY	$7.22 - $10.05 $4,635 - $6,452	642 Added 0.03%	2,335,992 $18.1 Million
Q2 2023 Aug 10, 2023	SELL	$4.89 - $10.57 $560,159 - $1.21 Million	-114,552 Reduced 4.68%	2,335,350 $23.2 Million
Q1 2023 May 11, 2023	BUY	$5.62 - $11.51 $1.13 Million - $2.3 Million	200,191 Added 8.9%	2,449,902 $14.2 Million
Q4 2022 Feb 13, 2023	BUY	$2.32 - $10.97 $848,987 - $4.01 Million	365,943 Added 19.43%	2,249,711 $17.9 Million

Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $771,770 - $2.3 Million	249,764 Added 15.29%	1,883,768 $5.95 Million
Q2 2022 Aug 11, 2022	BUY	$5.7 - $10.33 $885,044 - $1.6 Million	155,271 Added 10.5%	1,634,004 $9.36 Million
Q1 2022 May 13, 2022	BUY	$4.41 - $22.5 $2.92 Million - $14.9 Million	662,367 Added 81.14%	1,478,733 $10.4 Million
Q4 2021 Feb 11, 2022	BUY	$21.07 - $34.98 $627,696 - $1.04 Million	29,791 Added 3.79%	816,366 $18.7 Million
Q3 2021 Nov 09, 2021	BUY	$24.85 - $40.25 $19.5 Million - $31.7 Million	786,575 New	786,575 $23.3 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.